Sign In
Buy ABT
$93.24
+2.73 (+3.02%)
At Close: Jun 25, 2026
Absolute Software Co. (ABT.TO) (TSE:ABT) Stock Price Crosses Above Two Hundred Day Moving Average – Here’s Why
02:30am, Friday, 13'th Mar 2026
Absolute Software Co. (ABT.TO) (TSE: ABT - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of C$0.00 and trad
Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management
08:00am, Thursday, 12'th Mar 2026
U.K. FreeDM2 randomized controlled trial: At four months, people using Libre technology had a 0.6% greater reduction in HbA1c and 2.5 more hours a day in the healthy range vs. fingersticks 1,2 Improve
Abbott and Real Madrid launch nationwide effort to build the next 'Abbott Dream Team'
11:00am, Wednesday, 11'th Mar 2026
Abbott, in collaboration with Real Madrid, will host free selection events combining soccer and health education to identify the second annual 'Abbott Dream
Why Abbott (ABT) is a Top Value Stock for the Long-Term
10:41am, Wednesday, 11'th Mar 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Hope for the Best and Plan for the Worst: The 5 Safest Dividend Aristocrats
08:10am, Wednesday, 11'th Mar 2026
The stock market could face serious trouble in 2026 as extreme valuations collide with geopolitical tensions, AI investment skepticism, and policy headwinds.
Abbott (ABT) is a Top-Ranked Growth Stock: Should You Buy?
10:45am, Tuesday, 10'th Mar 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Focus Partners Advisor Solutions LLC Cuts Position in Abbott Laboratories $ABT
04:12am, Tuesday, 10'th Mar 2026
Focus Partners Advisor Solutions LLC trimmed its position in shares of Abbott Laboratories (NYSE: ABT) by 85.6% during the third quarter, according to its most recent Form 13F filing with the Securiti
Abbott (ABT) Rises Higher Than Market: Key Facts
06:50pm, Monday, 09'th Mar 2026
Abbott (ABT) reached $112.65 at the closing of the latest trading day, reflecting a +2.82% change compared to its last close.
Abbott Laboratories Offers Long-Term Upside Despite Recent Stumbles
09:47am, Monday, 09'th Mar 2026
Abbott Laboratories (ABT) remains a Buy, with the stock undervalued at $109.56 despite recent execution missteps and Nutrition segment weakness. Core Devices and Diagnostics segments continue to deliv
First Trust Advisors LP Buys 810,684 Shares of Abbott Laboratories $ABT
04:55am, Saturday, 07'th Mar 2026
First Trust Advisors LP increased its stake in Abbott Laboratories (NYSE: ABT) by 26.5% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commissio
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
10:00am, Wednesday, 04'th Mar 2026
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
Absolute Software Co. (ABT.TO) (TSE:ABT) Stock Price Crosses Above 200 Day Moving Average – Should You Sell?
03:00am, Tuesday, 03'rd Mar 2026
Absolute Software Co. (ABT.TO) (TSE: ABT - Get Free Report)'s share price passed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of C$0.00 and traded
Abbott (ABT) Stock Sinks As Market Gains: Here's Why
06:50pm, Monday, 02'nd Mar 2026
Abbott (ABT) closed at $114.12 in the latest trading session, marking a -1.92% move from the prior day.
Abbott Laboratories $ABT Shares Sold by Banco Santander S.A.
04:29am, Saturday, 28'th Feb 2026
Banco Santander S.A. reduced its holdings in Abbott Laboratories (NYSE: ABT) by 12.7% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and
Best Dividend Aristocrats For March 2026
12:21pm, Friday, 27'th Feb 2026
The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) is up 9.39% YTD in 2026, decisively outperforming SPY's 1.08%. Dividend Aristocrats are regaining momentum after a weak 2025, with 55 outpacing SPY
